What Researchers Did
Researchers designed four randomized controlled trials to investigate the efficacy of hyperbaric oxygen therapy for post-concussion syndrome in U.S. service members.
What They Found
These four randomized controlled trials were designed to enroll a total of 242 service members experiencing post-concussion syndrome. Participants would undergo 40 sessions over eight to 11 weeks, with conditions ranging from sham (1.2 atm abs, room air) to active hyperbaric oxygen (2.4 atm abs, 100% oxygen). Outcomes were planned for baseline, post-exposure, and three to 12 months' follow-up.
What This Means for Canadian Patients
While this study describes the design of trials for U.S. service members, successful completion and positive results could inform future treatment options for Canadian patients with post-concussion syndrome. If proven effective, hyperbaric oxygen therapy might offer a new therapeutic approach for persistent symptoms following mild traumatic brain injury in Canada.
Canadian Relevance
This study describes the design of clinical trials conducted by the U.S. Department of Defense and Department of Veterans Affairs, and therefore has no direct Canadian connection.
Study Limitations
A primary limitation of this publication is that it describes the design of clinical trials and does not present any actual study findings or efficacy data.